Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 158 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Indications for Datopotamab Deruxtecan High-Dose Chemotherapy Followed by ASCT Improves Survival Compared with Non-myeloablative Consolidation in Primary CNS Lymphoma ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment of metastatic pancreatic cancer MOST POPULAR Inside Cancer Grand Challenges Part 1: what makes a grand challenge? June 16, 2022 Rare Disease Day: Raising Awareness for Rare Cancers February 26, 2021 How targeted screening can help the NHS save lives from lung... November 23, 2022 Socioeconomic Deprivation Associated with Worse Survival in Patients with Cancer Included... March 23, 2021 Load more HOT NEWS Army Veteran Gets Life-Saving Heart Transplant: ‘It’s A True Miracle’ Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves... ESMO Breast Cancer Virtual Congress 2021, 5-8 May Similar Disease-Free Survival with Extended Intermittent or Continuous Treatment with Letrozole...
